Tamar Farfel-Becker

Investing Profile

Sweet spot: $1.5M Range: $100K–$5M

aMoon Fund thesis

Yahoo! Finance Guardant buys MetaSight for $59M upfront to acquire blood test tech February 23, 2026 CTech Seizing the HealthTech opportunity: Early-stage innovation takes center stage April 29, 2024 CTech Qumra’s Top 11: The Israeli startups to watch out for in 2024 March 4, 2024 Fierce Healthcare Omada GLP-1 program to prioritize muscle mass restoration through expanded care track February 13, 2024 Yahoo Finance Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing January 9, 2024 July 4, 2024 Taking the Tem

Sector and stage focus

  • Seed: Medical Devices, Pharmaceuticals, Consumer Health, Health IT, Digital Health, Health & Hospital Services
  • Series A: Consumer Health, Medical Devices, Pharmaceuticals, Health IT, Health & Hospital Services, Digital Health
  • general: Israel

Is Tamar Farfel-Becker a fit for your round?

Upload your pitch deck and see whether Tamar Farfel-Becker appears in your top 20 matches.

Find investors for your deck